A randomized, placebo-controlled double-blind, study evaluating the effect of pirfenidone in patients with chronic kidney disease and diabetes mellitus
Phase 2
- Conditions
- Chronic kidney disease patients associated with diabetes mellitus
- Registration Number
- JPRN-UMIN000014967
- Lead Sponsor
- Meiyo Clinic, Hemodialysis Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1)Items prohibited in pirfenidone package insert 2)History of allergy to lactose used as placebo 3)Investigator concludes that the patient's participation in this study is inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method